Back to Search
Start Over
ViiV Healthcare presents 'positive' proof-of-concept findings for N6LS
- Source :
- The Fly. October 25, 2022
- Publication Year :
- 2022
-
Abstract
- ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), with Pfizer (PFE) and Shionogi (SGIOY) as shareholders, announced 'positive' findings from its phase IIa proof-of-concept study of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.723971986